Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes Mellitus
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to perform a randomized trial to investigate if intrapartum
insulin delivery mechanisms reduces adverse outcomes associated with type 1 diabetes in
pregnancy. The investigators aim to compare subcutaneous insulin pump versus intravenous
insulin infusion with regard to the primary outcome of neonatal blood sugar.